METHODS | Randomization procedure: | ||||
Allocation: | |||||
Blinding: | |||||
Duration: | |||||
Design: | |||||
Multicentre: | |||||
Analysis (ITT): | |||||
Informed consent: | |||||
PARTICIPANTS | N: | ||||
Setting: | |||||
Age: | O: | C: | B: | ||
Gender: | O: | C: | B: | ||
Diagnostic criteria: | |||||
History: | |||||
Excluded: | |||||
NOTES | |||||
INTERVENTIONS OUTCOMES |
Intervention: | ( ) CPAP ( ) bilevel NPPV ( ) Other | |||
PEEP level: | C: | B: | |||
PS level: | B: | ||||
N: | C: | B: | |||
Time: | C: | B: | |||
Co‐intervention: | |||||
Control group: | ( ) O2 ( ) Co‐intervention ( ) Other | ||||
N: | |||||
Mask: | ( ) oro‐nasal ( ) nasal ( ) total face ( ) other | ||||
Mortality: | O: | C: | B: | ||
Tracheal intubation rate: | O: | C: | B: | ||
ICU length of stay: | O: | C: | B: | ||
Hospital length of stay: | O: | C: | B: | ||
Treatment failure: | O: | C: | B: | ||
Adverse effects: | O: | C: | B: | ||
Patient compliance : | O: | C: | B: | ||
Drop‐outs / withdrawals: | O: | C: | B: | ||
Notes |